Barely Significant
← all excerpts

Phase II Study of Cabozantinib in Patients With Bone Metastasis.

Oncologist · 2022 · PMC9256024 · PMID 35524758

1
hedged sentence
closest p
boldest claim

The sentences

quite significantno p-value reported
For some, the duration of response proved to also be quite significant.

also in 5,695 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.